Literature DB >> 27081515

A novel KCNT1 mutation in a Japanese patient with epilepsy of infancy with migrating focal seizures.

Shino Shimada1, Yoshiko Hirano2, Susumu Ito2, Hirokazu Oguni2, Satoru Nagata2, Keiko Shimojima3, Toshiyuki Yamamoto3.   

Abstract

Epilepsy of infancy with migrating focal seizures (EIFMS) is a rare, early-onset epileptic encephalopathy characterized by polymorphous focal seizures. De novo mutations of KCNT1 have been identified in cases of this disorder. We encountered a sporadic patient with EIFMS, who suffered tonic convulsions at the age of 9 days. Using Sanger sequencing, we identified a de novo missense mutation of the same amino acid affected by a previously identified mutation, c.1420C>T (p.Arg474Cys).

Entities:  

Year:  2014        PMID: 27081515      PMCID: PMC4777018          DOI: 10.1038/hgv.2014.27

Source DB:  PubMed          Journal:  Hum Genome Var        ISSN: 2054-345X


Epilepsy of infancy with migrating focal seizures (EIFMS), first described as migrating partial seizures of infancy (MMPSI) in 1995, is a rare, early-onset epileptic encephalopathy characterized by polymorphous focal seizures that commence within the first 6 months after birth.[1] This clinical condition is classified as early infantile epileptic encephalopathy 14 (MIM #614959) by the online database Mendelian inheritance in man (OMIM; http://www.omim.org/). Seizures are pharmacoresistant and ictal electroencephalogram (EEG) discharges show migrating ictal foci. In 2012, mutations of the potassium channel, subfamily T, member 1 gene (KCNT1; MIM #608167) located at 9q34.3 were identified in familial patients with severe autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE; MIM #615005) associated with intellectual/psychiatric problems.[2] Also, de novo mutations of KCNT1 were reported in 6 out of 12 unrelated patients (50%) with EIFMS,[3] indicating the existence of clinical heterogeneity within KCNT1 mutations. Those results suggested that familial mutations and de novo mutations of KCNT1 correlate with ADNFLE and EIFMS, respectively. Different mutations of KCNT1 were identified by subsequent analyses in EIFMS patients.[4] These findings suggested that KCNT1 is the major disease-associated gene for the EIFMS phenotype. KCNT1 encodes a sodium-activated potassium (KNa) channel that is highly expressed in the nervous system.[3] It is thought to regulate hyperpolarization following repetitive firing. The C-terminal cytoplasmic domain of KCNT1 interacts with a protein network, including the Fragile X mental retardation protein, thus stimulating the KCNT1 channel.[5] Barcia et al.[3] reported that mutations in the cytoplasmic C-terminal domain lead to constitutive activation of the KCNT1 channel. Our previous study reported two unrelated patients with EIFMS caused by a de novo missense mutation at the pore region of the KCNT1 channel.[4] In the present study, we report on a 6-month-old Japanese male infant, the first child of nonconsanguineous healthy parents, born at 39 weeks of gestation using vacuum extraction because of diminished heart sounds. The child experienced an episode of apnea 4 days after delivery and tonic convulsions at day 9. Seizures evolved to frequent focal motor seizures that alternated from one side of the body to the other. Ictal EEGs showed asynchronous multifocal spikes derived from both brain hemispheres (Figure 1a). Seizures were intractable and easily led to status epilepticus, occurring in clusters. The child’s psychomotor development was markedly delayed, he was confined to his bed and exhibited poor responses to his surroundings. Brain magnetic resonance imaging (MRI) conducted at 6 months of age showed delayed myelination and thin corpus callosum (Figure 1b). These findings have been supported by a cohort study of 14 patients with EIFMS, one-third of the patients exhibited delayed myelination with white matter hyperintensity revealed by a brain MRI6 and 3 among the 6 patients with KCNT1 mutations showed a thin corpus collosum.[3] On the basis of these clinical features, the child was diagnosed with EIFMS.
Figure 1

Patient clinical information. (a) Ictal electroencephalogram (EEG) examined at 6 months. A short EEG seizure discharge begins at the right frontal region. (b–d) Brain magnetic resonance imaging examined at 6 months. Extracerebral spaces can be seen in axial images, (b and c) possibly indicating brain atrophy. Both (b) T1- and (c) T2-weighted images show high intensity in the deep white matter, indicating delayed myelination. (d) The corpus callosum is thin in the T1-weighted sagittal image.

This study has been approved by Ethics Committee of Tokyo Women’s Medical University. Upon obtaining written informed consent from the patient’s family, mutation analysis using standard Sanger sequencing was performed for all exons of KCNT1 and a heterozygous missense mutation (c.1420C>T, p.Arg474Cys) identified in exon 15 was the only variant found (Figure 2). Because both parents did not exhibit this mutation, it was determined to be de novo in origin. This alteration has not been previously reported and is not found in the single-nucleotide variation database (https://genome.ucsc.edu/). The affected amino acid is highly conserved among species (Figure 2). A de novo missense mutation at the same amino-acid, p.Arg474His, has been reported in a patient with EIFMS.[3] The clinical features of both patients with amino-acid changes at p.Arg474 are summarized in Table 1. Because both patients shared quite similar clinical characteristics, we concluded that p.Arg474Cys identified in this study could be pathogenic.
Figure 2

Electropherogram and corresponding genomic data. The electropherogram of the KCNT1 exon 15 indicates a heterozygous missense mutation, c.1420C>T (p.Arg474Cys), in KCNT1. The affected residue is conserved across species. Although there are some single-nucleotide variants (SNVs) proximal to the identified mutation, the same SNVs are not found in the database.

Table 1

Comparison of the clincial features of the patients with missense mutation at p.Arf474

Patient's clinical features Patient 5 by Barcia et al. (2012) Patient in this study
GenderMM
Nucleotide alterationc.1421G>Ac.1420C>T
Amino-acid changep.Arg474Hisp.Arg474Cys
Ethnic originFranceJapan
Age at seizure onset2 weeks9 days
Seizure type at onsetFocal motorFocal motor
Neurological evaluation at onsetAxial hypotoniaAxial hypotonia
Age at observation6 months6 months
Neurological evaluationLack of contact Axial hypotoniaPoor response to the surroundings Axial hypotonia
MRI findings (age)Normal (at 1 month)Myelination delay and this corpus callosum (at 6 months)

Abbreviations: M, male; MRI, magnetic resonance imaging.

In conclusion, we identified a novel de novo missense mutation of KCNT1 in a patient with sporadic EIFMS. This finding provides additional evidence to better understand KCNT1 pathogenesis.
  6 in total

1.  A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.

Authors:  Atsushi Ishii; Mutsuki Shioda; Akihisa Okumura; Hiroyuki Kidokoro; Masako Sakauchi; Shino Shimada; Toshiaki Shimizu; Makiko Osawa; Shinichi Hirose; Toshiyuki Yamamoto
Journal:  Gene       Date:  2013-09-10       Impact factor: 3.688

2.  Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Sarah E Heron; Katherine R Smith; Melanie Bahlo; Lino Nobili; Esther Kahana; Laura Licchetta; Karen L Oliver; Aziz Mazarib; Zaid Afawi; Amos Korczyn; Giuseppe Plazzi; Steven Petrou; Samuel F Berkovic; Ingrid E Scheffer; Leanne M Dibbens
Journal:  Nat Genet       Date:  2012-10-21       Impact factor: 38.330

3.  Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack.

Authors:  Maile R Brown; Jack Kronengold; Valeswara-Rao Gazula; Yi Chen; John G Strumbos; Fred J Sigworth; Dhasakumar Navaratnam; Leonard K Kaczmarek
Journal:  Nat Neurosci       Date:  2010-05-30       Impact factor: 24.884

4.  Migrating partial seizures in infancy: a malignant disorder with developmental arrest.

Authors:  G Coppola; P Plouin; C Chiron; O Robain; O Dulac
Journal:  Epilepsia       Date:  1995-10       Impact factor: 5.864

5.  Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum.

Authors:  Amy McTague; Richard Appleton; Shivaram Avula; J Helen Cross; Mary D King; Thomas S Jacques; Sanjay Bhate; Anthony Cronin; Andrew Curran; Archana Desurkar; Michael A Farrell; Elaine Hughes; Rosalind Jefferson; Karine Lascelles; John Livingston; Esther Meyer; Ailsa McLellan; Annapurna Poduri; Ingrid E Scheffer; Stefan Spinty; Manju A Kurian; Rachel Kneen
Journal:  Brain       Date:  2013-04-18       Impact factor: 13.501

6.  De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.

Authors:  Giulia Barcia; Matthew R Fleming; Aline Deligniere; Valeswara-Rao Gazula; Maile R Brown; Maeva Langouet; Haijun Chen; Jack Kronengold; Avinash Abhyankar; Roberta Cilio; Patrick Nitschke; Anna Kaminska; Nathalie Boddaert; Jean-Laurent Casanova; Isabelle Desguerre; Arnold Munnich; Olivier Dulac; Leonard K Kaczmarek; Laurence Colleaux; Rima Nabbout
Journal:  Nat Genet       Date:  2012-10-21       Impact factor: 38.330

  6 in total
  4 in total

1.  An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack KNa Currents.

Authors:  Imran H Quraishi; Shani Stern; Kile P Mangan; Yalan Zhang; Syed R Ali; Michael R Mercier; Maria C Marchetto; Michael J McLachlan; Eugenia M Jones; Fred H Gage; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2019-07-26       Impact factor: 6.167

Review 2.  The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel.

Authors:  Qi Zhang; Ye Liu; Jie Xu; Yue Teng; Zhe Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.

Authors:  Giulia Barcia; Nicole Chemaly; Mathieu Kuchenbuch; Monika Eisermann; Stéphanie Gobin-Limballe; Viorica Ciorna; Alfons Macaya; Laetitia Lambert; Fanny Dubois; Diane Doummar; Thierry Billette de Villemeur; Nathalie Villeneuve; Marie-Anne Barthez; Caroline Nava; Nathalie Boddaert; Anna Kaminska; Nadia Bahi-Buisson; Mathieu Milh; Stéphane Auvin; Jean-Paul Bonnefont; Rima Nabbout
Journal:  Neurol Genet       Date:  2019-10-25

4.  A KCNC1 mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation.

Authors:  Yalan Zhang; Syed R Ali; Rima Nabbout; Giulia Barcia; Leonard K Kaczmarek
Journal:  J Neurophysiol       Date:  2021-07-07       Impact factor: 2.974

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.